Inovio Pharmaceuticals, Inc. — Chart, Price & News (NASDAQ:INO)

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Market Capitalization 94.43 M
Employee 134
Founded 1999
CEO Jacqueline Shea
Website www.inovio.com
Headquarter Delaware, United States
FIGI BBG000BK6YX5
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

94.43 M Market capitalization

Price to earnings ratio

-0.46

Price to sales ratio

228.26

Dividends per share

—

Dividend yield %

—

Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.